Let’s be realistic. You’re NOT going to get rich in a hurry by investing in mainstream blue-chip stocks. The S&P 500 is a handy benchmark and a good proxy for the U.S. economy, but it’s not going to make anyone rich unless you have decades to invest. If you want to truly soar above the market, you have to dedicate at least part of… Read More

Let’s be realistic. You’re NOT going to get rich in a hurry by investing in mainstream blue-chip stocks. The S&P 500 is a handy benchmark and a good proxy for the U.S. economy, but it’s not going to make anyone rich unless you have decades to invest. If you want to truly soar above the market, you have to dedicate at least part of your portfolio to serious big-game hunting. With that in mind, my team and I just released a report on my boldest predictions for 2014. (On Wednesday, I told you about one prediction.) These are ideas that you won’t hear about in the mainstream financial press until it’s too late. In the past, my previous predictions have returned thousands of dollars to subscribers of my newsletter Game-Changing Stocks. Here’s a brief look at a few of the triple-digit winners… But my ideas for 2014 are some of the most… Read More

When you’re looking for explosive gains in stocks, getting in on the ground floor is everything… That’s why, as the chief investment strategist behind Game-Changing Stocks, it’s my job to predict “the next big thing” BEFORE it happens. Over the years, my research team and I have made a number of such predictions. Though they haven’t all played out the way we expected, many of them proved to be quite accurate. For instance, in 2009 we predicted there would be a big… Read More

When you’re looking for explosive gains in stocks, getting in on the ground floor is everything… That’s why, as the chief investment strategist behind Game-Changing Stocks, it’s my job to predict “the next big thing” BEFORE it happens. Over the years, my research team and I have made a number of such predictions. Though they haven’t all played out the way we expected, many of them proved to be quite accurate. For instance, in 2009 we predicted there would be a big move in nanotechnology. In the months that followed, our nanotech pick shot up 293%. Then in 2010, we predicted the “best sci-fi speculation of the year” would be a powerful technology called RFID… and that three stocks could skyrocket because of it. Our picks were up 42%… 89%… and 310% a year after we forecast our projections. And last year, we predicted that “Apple (Nasdaq: AAPL) would stumble without Steve Jobs.” This chart speaks for itself: The list goes on… Today, I want to share… Read More

When you’re looking for explosive gains in stocks, getting in on the ground floor is everything… That’s why, as the chief investment strategist behind Game-Changing Stocks, it’s my job to predict “the next big thing” BEFORE it happens. Over the years, my research team and I have made a number of such predictions. Though they haven’t all played out the way we expected, many of them proved to be quite accurate. For instance, in 2009 we predicted there would be a… Read More

When you’re looking for explosive gains in stocks, getting in on the ground floor is everything… That’s why, as the chief investment strategist behind Game-Changing Stocks, it’s my job to predict “the next big thing” BEFORE it happens. Over the years, my research team and I have made a number of such predictions. Though they haven’t all played out the way we expected, many of them proved to be quite accurate. For instance, in 2009 we predicted there would be a big move in nanotechnology. In the months that followed, our nanotech pick shot up 293%. Then in 2010, we predicted the “best sci-fi speculation of the year” would be a powerful technology called RFID… and that three stocks could skyrocket because of it. Our picks were up 42%… 89%… and 310% a year after we forecast our projections. And last year, we predicted that “Apple (Nasdaq: AAPL) would stumble without Steve Jobs.” This chart speaks for itself: The list goes on… Today, I want… Read More

Success can be fatal in technology. That’s because success leads to growth, and that frequently stifles the original creativity and innovative spirit that made the company great in the first place. That predictable cycle has been on display once again in the past few years, with industry leaders Microsoft (Nasdaq: MSFT) and Intel (Nasdaq: INTC) failing to capitalize fully on growth in mobile markets. In the dynamic technology sector, the biggest and most successful companies sometimes struggle to stay current with the latest trends, much less lead the… Read More

Success can be fatal in technology. That’s because success leads to growth, and that frequently stifles the original creativity and innovative spirit that made the company great in the first place. That predictable cycle has been on display once again in the past few years, with industry leaders Microsoft (Nasdaq: MSFT) and Intel (Nasdaq: INTC) failing to capitalize fully on growth in mobile markets. In the dynamic technology sector, the biggest and most successful companies sometimes struggle to stay current with the latest trends, much less lead the market with groundbreaking technology or innovation. But one well-known technology giant is breaking the mold. Few companies have ever experienced such a meteoric rise, with shares up 750% after going public less than 10 years ago, making it one of the most valuable in the world. But unlike many other mega-cap market leaders content to let growth stifle innovation, this company continues to produce market-leading technology in multiple high-growth markets.#-ad_banner-# Google (Nasdaq: GOOG) is already one of… Read More

Success can be fatal in technology. That’s because success leads to growth, and that frequently stifles the original creativity and innovative spirit that made the company great in the first place. That predictable cycle has been on display once again in the past few years, with industry leaders Microsoft (Nasdaq: MSFT) and Intel (Nasdaq: INTC) failing to capitalize fully on growth in mobile markets. In the dynamic technology sector, the biggest and most successful companies sometimes struggle to stay current with the latest trends, much less lead the… Read More

Success can be fatal in technology. That’s because success leads to growth, and that frequently stifles the original creativity and innovative spirit that made the company great in the first place. That predictable cycle has been on display once again in the past few years, with industry leaders Microsoft (Nasdaq: MSFT) and Intel (Nasdaq: INTC) failing to capitalize fully on growth in mobile markets. In the dynamic technology sector, the biggest and most successful companies sometimes struggle to stay current with the latest trends, much less lead the market with groundbreaking technology or innovation. But one well-known technology giant is breaking the mold. Few companies have ever experienced such a meteoric rise, with shares up 750% after going public less than 10 years ago, making it one of the most valuable in the world. But unlike many other mega-cap market leaders content to let growth stifle innovation, this company continues to produce market-leading technology in multiple high-growth markets.#-ad_banner-# Google (Nasdaq: GOOG) is already one of… Read More

If you’re like millions of investors, you’ve decided against investing in Facebook (Nasdaq: FB). The company’s hotly-anticipated IPO in the spring of 2012 was a bust, and over subsequent quarters, shares have been adrift at sea. Indeed, as the S&P 500 has tacked on additional robust gains this year, shares of Facebook have quietly sunk below the 100-day… Read More

If you’re like millions of investors, you’ve decided against investing in Facebook (Nasdaq: FB). The company’s hotly-anticipated IPO in the spring of 2012 was a bust, and over subsequent quarters, shares have been adrift at sea. Indeed, as the S&P 500 has tacked on additional robust gains this year, shares of Facebook have quietly sunk below the 100-day moving average. Of course, like many other investors, you’ve tucked this stock away into the back of your mind, planning on giving it a fresh look when the current phase of malaise has passed. Well, the time has come to give this broken IPO a fresh look. And when you do, you’ll find a business model that is finally ripening, with many arrows in its quiver. Facebook’s 2013 sales and profit trends may… Read More

If you’re like millions of investors, you’ve decided against investing in Facebook (Nasdaq: FB). The company’s hotly-anticipated IPO in the spring of 2012 was a bust, and over subsequent quarters, shares have been adrift at sea. Indeed, as the S&P 500 has tacked on additional robust gains this year, shares of Facebook have quietly sunk below the 100-day… Read More

If you’re like millions of investors, you’ve decided against investing in Facebook (Nasdaq: FB). The company’s hotly-anticipated IPO in the spring of 2012 was a bust, and over subsequent quarters, shares have been adrift at sea. Indeed, as the S&P 500 has tacked on additional robust gains this year, shares of Facebook have quietly sunk below the 100-day moving average. Of course, like many other investors, you’ve tucked this stock away into the back of your mind, planning on giving it a fresh look when the current phase of malaise has passed. Well, the time has come to give this broken IPO a fresh look. And when you do, you’ll find a business model that is finally ripening, with many arrows in its quiver. Facebook’s 2013 sales and… Read More

Let me tell you about a guy I know named Nat. Nat’s known for enjoying the finer things in life. His 40th birthday was held at a marina in billionaire hotspot Montenegro. Palm trees were flown in from Uruguay. Caterers were brought in specially from London. Billionaires from across the globe were in attendance. How did Nat join the billionaire elite? On the surface, he appears to have built his more than $1.5 billion personal fortune in the metals and mining industries. But look a little deeper and you’ll see that Nat’s biggest advantage has been his family’s reputation and… Read More

Let me tell you about a guy I know named Nat. Nat’s known for enjoying the finer things in life. His 40th birthday was held at a marina in billionaire hotspot Montenegro. Palm trees were flown in from Uruguay. Caterers were brought in specially from London. Billionaires from across the globe were in attendance. How did Nat join the billionaire elite? On the surface, he appears to have built his more than $1.5 billion personal fortune in the metals and mining industries. But look a little deeper and you’ll see that Nat’s biggest advantage has been his family’s reputation and financial backing.#-ad_banner-# That’s because Nat is short for Nathaniel. His full name is Nathaniel Philip Victor James Rothschild. He’s the latest descendant of the legendary Rothschild family… one of the world’s most powerful dynasties since the late 18th century. For over 200 years, the secretive family has had a hand in just about every major world event. Whether it’s bringing down Napoleon… building the Suez Canal… financing the California Gold Rush… or ushering in the railroad era… look closely and you’ll find Rothschild fingerprints everywhere. Early on, the family made it a point to pass the… Read More

Biotech investing is like the Wild West: Anything can — and does — happen.  Inexpensive stocks in this sector can shoot higher on signals of positive test results. By the same token, top-performing biotech shares can plummet when a flagship product fails to gain regulatory approval or is forced into irrelevancy by a competitor.  Even companies that appear to be up-and-coming industry leaders can quickly fade into… Read More

Biotech investing is like the Wild West: Anything can — and does — happen.  Inexpensive stocks in this sector can shoot higher on signals of positive test results. By the same token, top-performing biotech shares can plummet when a flagship product fails to gain regulatory approval or is forced into irrelevancy by a competitor.  Even companies that appear to be up-and-coming industry leaders can quickly fade into has-been status on news of a minor negative occurrence. In other words, while the biotech investing arena can sometimes offer rapid returns, it is only for investors who can stomach risk. One tactic used by the most successful investors in this arena is to spread risk across multiple stocks. This tactic relies on speculating that one or more will be a huge winner, creating profits for the portfolio despite the almost guaranteed losers.  The latest biotech company catching my attention is Exact… Read More

Biotech investing is like the Wild West: Anything can — and does — happen.  Inexpensive stocks in this sector can shoot higher on signals of positive test results. By the same token, top-performing biotech shares can plummet when a flagship product fails to gain regulatory approval or is forced into irrelevancy by a competitor.  Even companies that appear to be up-and-coming industry leaders can quickly fade into… Read More

Biotech investing is like the Wild West: Anything can — and does — happen.  Inexpensive stocks in this sector can shoot higher on signals of positive test results. By the same token, top-performing biotech shares can plummet when a flagship product fails to gain regulatory approval or is forced into irrelevancy by a competitor.  Even companies that appear to be up-and-coming industry leaders can quickly fade into has-been status on news of a minor negative occurrence. In other words, while the biotech investing arena can sometimes offer rapid returns, it is only for investors who can stomach risk. One tactic used by the most successful investors in this arena is to spread risk across multiple stocks. This tactic relies on speculating that one or more will be a huge winner, creating profits for the portfolio despite the almost guaranteed losers.  The latest biotech company catching my attention is Exact… Read More